GlassScriptPhysician profile
Deborah I Lauridsen
NPI 1851338321
$5,469.72
in general payments reported to CMS, 2019-2025
44 companies · $850 in 2025
The $850 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $958 · 2021: $1,502 · 2022: $702 · 2023: $502 · 2024: $620 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,972.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $935.81 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $446.65 | 2020-2021 | |
| Amgen INC. | $422.00 | 2019-2025 | Repatha, Otezla |
| Novo Nordisk INC | $391.84 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $303.05 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Astellas Pharma US INC | $275.33 | 2019-2025 | Veozah |
| Lilly USA, LLC | $252.01 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Janssen Pharmaceuticals, INC | $248.49 | 2019-2022 | |
| Amarin Pharma, INC. | $170.62 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $167.97 | 2020-2021 | |
| Ibsa Pharma INC. | $161.02 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.97 | 2021-2025 | Jardiance, Synjardy |
| Exact Sciences Corporation | $153.22 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $123.44 | 2019-2023 | Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $119.03 | 2022-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Lauridsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.